The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myelomaG. Wei Xu, Aaron D. Schimmer, Xiaoming Li et al.|Blood|2010Cited by 168
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Jie Luo et al.|Cell Reports Medicine|2024Cited by 28
Altered Brain Activation in Early Drug-Naive Parkinson’s Disease during Heat Pain Stimuli: An fMRI StudyYing Tan, Xiaoming Wang, Juan Tan et al.|Parkinson s Disease|2015Cited by 20
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean C. Tien, Arul M. Chinnaiyan, Yu Chang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1